Technical Analysis for ESPR - Esperion Therapeutics, Inc.

Grade Last Price % Change Price Change
F 22.24 -3.43% -0.79
ESPR closed up 4.82 percent on Wednesday, May 12, 2021, on 1.16 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ESPR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion -3.43%
Calm After Storm Range Contraction 1.23%
Wide Bands Range Expansion 1.23%
180 Bearish Setup Bearish Swing Setup 0.41%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.41%
Calm After Storm Range Contraction 0.41%
Lower Bollinger Band Walk Weakness 0.41%
Wide Bands Range Expansion 0.41%
Lower Bollinger Band Walk Weakness -0.22%
Wide Bands Range Expansion -0.22%
Older End-of-Day Signals for ESPR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 1 hour ago
60 Minute Opening Range Breakdown about 1 hour ago
Down 2 % about 1 hour ago
Rose Above Previous Day's High about 3 hours ago
10 DMA Resistance about 3 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Diabetes Lipid Cardiology Obesity Cholesterol Lipoprotein Lipids Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Niacin Atherosclerosis Lipoproteins

Is ESPR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 53.73
52 Week Low 18.01
Average Volume 642,448
200-Day Moving Average 30.74
50-Day Moving Average 27.29
20-Day Moving Average 25.62
10-Day Moving Average 23.68
Average True Range 1.67
ADX 23.57
+DI 18.26
-DI 36.37
Chandelier Exit (Long, 3 ATRs ) 23.76
Chandelier Exit (Short, 3 ATRs ) 23.03
Upper Bollinger Band 31.00
Lower Bollinger Band 20.25
Percent B (%b) 0.26
BandWidth 41.94
MACD Line -1.56
MACD Signal Line -1.16
MACD Histogram -0.4013
Fundamentals Value
Market Cap 642 Million
Num Shares 27.9 Million
EPS -2.86
Price-to-Earnings (P/E) Ratio -8.04
Price-to-Sales 3.59
Price-to-Book 88.48
PEG Ratio -4.78
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.69
Resistance 3 (R3) 25.46 24.35 25.24
Resistance 2 (R2) 24.35 23.67 24.46 25.09
Resistance 1 (R1) 23.69 23.26 24.02 23.92 24.95
Pivot Point 22.58 22.58 22.75 22.69 22.58
Support 1 (S1) 21.92 21.90 22.25 22.15 21.11
Support 2 (S2) 20.81 21.49 20.92 20.97
Support 3 (S3) 20.15 20.81 20.82
Support 4 (S4) 20.38